Geographic distribution of United States clinical trial sites utilized for guideline changing studies of cholesterol management
Study context
- Population
- United States (US) clinical trial sites used for guideline-changing randomised trials of pharmacologic cholesterol treatment (site location data from ClinicalTrials.gov)
- Exposure
- US counties with vs without clinical trial sites
- Outcome
- Geographic distribution of US clinical trial sites
Main finding
As reported in the abstract
- Half of US counties were over 30 miles from a study site
- Social determinants of health more favorable in counties with vs without trial sites
Observational data: associations, not effects.
Original publication
Geographic distribution of United States clinical trial sites utilized for guideline changing studies of cholesterol management. Am Heart J. Published 26 June 2023. doi:10. 1016/ j. ahj. 2023. 03. 020
Composed by AI from the published abstract and checked against it. How Briefs are made →